A Comparison of SARS-CoV-2 Infection-related and COVID-19 Vaccine-related Herpes Zoster; A Narrative Review

Authors

  • Zeinab Mohseni Afshar
  • Zeinab Aryanian
  • Anahita Tabavar
  • Parvaneh Hatami
  • Alireza Janbakhsh
  • Azadeh Goodarzi
  • Ehsan Alavi Rad

DOI:

https://doi.org/10.47750/pnr.2022.13.S03.111

Keywords:

COVID-19, SARS-CoV-2, Varicella Zoster Virus, Zoster, Zona, COVID-19 Vaccine, Vaccination, Virus Reactivation, Comparative, Review.

Abstract

The are many cases of coincidence of herpes zoster in prei-COVID-19 infection or post-COVID-19 vaccination period and some expert or specialist experiences about increased prevalence of zona in the COVID-19 era that highlights the probability of SARS-CoV-2 infection and vaccine associated immune dysregulation that reactivates latent varicella zoster virus (VZV) infection. In this comprehensive comparative review we have discussed the various aspects of COVID-19 pandemic-related zona as the peri-COVID or post-vaccine zoster which is considered as one of the most prevalent dermatological adverse reactions in such circumstances and should be diagnosed and managed in the best possible way. By a comparative approach there are many similarities and differences regarding herpes zoster in theses 2 certain conditions.

Downloads

Published

2022-09-22

Issue

Vol. 13 SPECIAL ISSUE 03 (2022)

Section

Articles

How to Cite

A Comparison of SARS-CoV-2 Infection-related and COVID-19 Vaccine-related Herpes Zoster; A Narrative Review. (2022). Journal of Pharmaceutical Negative Results, 734-738. https://doi.org/10.47750/pnr.2022.13.S03.111